Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Marker Therapeutics (MRKR) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for Marker Therapeutics (MRKR) over the last 2 years, with Q1 2025 value amounting to $453135.0.

  • Marker Therapeutics' Other Operating Expenses changed N/A to $453135.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $453135.0, marking a year-over-year change of. This contributed to the annual value of $116.0 million for FY2018, which is N/A changed from last year.
  • Per Marker Therapeutics' latest filing, its Other Operating Expenses stood at $453135.0 for Q1 2025.
  • Marker Therapeutics' 5-year Other Operating Expenses high stood at $453135.0 for Q1 2025, and its period low was $453135.0 during Q1 2025.